Lack of CD56 expression has been associated with a number of adverse clinicopathologic factors including higher B2M levels and higher incidence of renal insufficiency and therefore thought to represent more aggressive disease (26, 50). The gene discussed is NCAM1; the disease is Renal insufficiency.